Meda AB Announces Extended Employment for CEO

STOCKHOLM, Sweden--(BUSINESS WIRE)-- Meda’s (STO:MEDAA) board of directors and CEO Anders Lönner has reached agreement regarding an extended employment until mid 2012.

MEDA AB (publ) is a leading international specialty pharma company. The company specialises in marketing and pharmaceutical development in late clinical stage. Acquisitions and long-term partnerships are fundamental factors that drive the company’s strategy. Meda is represented by its own organisations in about 40 countries. Meda’s products are sold in 120 countries worldwide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit www.meda.se.

This information was brought to you by Cision http://www.cisionwire.com

Contact:

Meda Anders Larnholt, Vice President Investor Relations tel. +46 709 458 878

Source: Meda

Back to news